ATC
GILD icon

Advantage Trust Company’s Gilead Sciences GILD Stock Holding History

Advantage Trust Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4K Buy
138
+100
+263% +$13.2K 0.01% 153
2026
Q1 		$5.3K Hold
38
– – ﹤0.01% 115
2025
Q4 		$4.66K Sell
38
-100
-72% -$12.2K ﹤0.01% 115
2025
Q3 		$15.3K Sell
138
-700
-84% -$79.6K 0.01% 157
2025
Q2 		$92.9K Buy
838
+100
+14% +$10.6K 0.05% 94
2025
Q1 		$82.7K Buy
738
+38
+5% +$3.92K 0.05% 75
2024
Q4 		$64.7K Hold
700
– – 0.04% 87
2024
Q3 		$58.7K Hold
700
– – 0.04% 95
2024
Q2 		$48K Sell
700
-100
-13% -$6.67K 0.03% 114
2024
Q1 		$58.6K Hold
800
– – 0.04% 101
2023
Q4 		$64.8K Buy
+800
New +$62.3K 0.05% 98

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Advantage Trust Company's GILD Position: Q2 2026 in Review

Advantage Trust Company increased its Gilead Sciences (GILD) stake by 263% in Q2 2026, buying an estimated $13.2K and bringing the position to 138 shares worth $17.4K. The position accounts for 0.01% of the portfolio, ranked #153.

Advantage Trust Company first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $92.9K in Q2 2025. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Advantage Trust Company held 138 shares of Gilead Sciences worth $17.4K as of Q2 2026.
  • Advantage Trust Company bought 100 Gilead Sciences shares in Q2 2026, an estimated $13.2K.
  • Gilead Sciences made up 0.01% of Advantage Trust Company's portfolio in Q2 2026, its #153 holding.
  • Advantage Trust Company first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Advantage Trust Company's Gilead Sciences position peaked at $92.9K in Q2 2025.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Advantage Trust Company's 13F filing for Q2 2026, filed 17 Jul 2026.